ATE235509T1 - Peptide zur inhibition von hpv e7 proteinen - Google Patents

Peptide zur inhibition von hpv e7 proteinen

Info

Publication number
ATE235509T1
ATE235509T1 AT98112047T AT98112047T ATE235509T1 AT E235509 T1 ATE235509 T1 AT E235509T1 AT 98112047 T AT98112047 T AT 98112047T AT 98112047 T AT98112047 T AT 98112047T AT E235509 T1 ATE235509 T1 AT E235509T1
Authority
AT
Austria
Prior art keywords
proteins
hpv
peptides
inhibition
well
Prior art date
Application number
AT98112047T
Other languages
English (en)
Inventor
Pidder Dr Jansen-Duerr
Werner Dr Zwerschke
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of ATE235509T1 publication Critical patent/ATE235509T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT98112047T 1998-06-30 1998-06-30 Peptide zur inhibition von hpv e7 proteinen ATE235509T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98112047A EP0969013B1 (de) 1998-06-30 1998-06-30 Peptide zur Inhibition von HPV E7 Proteinen

Publications (1)

Publication Number Publication Date
ATE235509T1 true ATE235509T1 (de) 2003-04-15

Family

ID=8232194

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98112047T ATE235509T1 (de) 1998-06-30 1998-06-30 Peptide zur inhibition von hpv e7 proteinen

Country Status (6)

Country Link
EP (1) EP0969013B1 (de)
JP (1) JP2002519357A (de)
AT (1) ATE235509T1 (de)
AU (1) AU5155699A (de)
DE (1) DE69812597D1 (de)
WO (1) WO2000000509A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608026B1 (en) 2000-08-23 2003-08-19 Board Of Regents, The University Of Texas System Apoptotic compounds
US7167801B2 (en) 2001-07-12 2007-01-23 Boehringer Ingelheim (Canada) Ltd. Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates
CU23225A1 (es) * 2001-12-20 2007-08-30 Ct Ingenieria Genetica Biotech PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0531080A3 (en) * 1991-09-04 1993-12-29 Merck & Co Inc Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene protein
US5625031A (en) * 1994-02-08 1997-04-29 Bristol-Myers Squibb Company Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein
US6037125A (en) * 1996-11-05 2000-03-14 Lexicon Genetics Incorporated Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells
DE19649606C1 (de) * 1996-11-29 1997-10-02 Deutsches Krebsforsch Systeme zur Bestimmung von Wirksubstanzen gegen HPV-assoziierte Karzinome

Also Published As

Publication number Publication date
WO2000000509A3 (en) 2000-04-13
JP2002519357A (ja) 2002-07-02
EP0969013B1 (de) 2003-03-26
AU5155699A (en) 2000-01-17
EP0969013A1 (de) 2000-01-05
WO2000000509A2 (en) 2000-01-06
DE69812597D1 (de) 2003-04-30

Similar Documents

Publication Publication Date Title
EA200400241A1 (ru) Направленные к мишени мультимерные контрастные вещества, основанные на пептидах
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
ES2063278T3 (es) Proteina morfogenetica de hueso.
ATE270280T1 (de) Substituierte dipeptide zur förderung der sekretion von wachstumshormon
RU95115239A (ru) Аналог эритропоэтина
DE69713112D1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin-analogen
ZA200201032B (en) Monomeric protein of the TG-β family.
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
DE60207759D1 (de) Pyrimidotriazine als phosphataseinhibitoren
BR0312521A (pt) Métodos para a separação e a purificação de fibrinogênio e de pelo menos uma outra proteìna e para a co-purificação de fibrinogênio e de fator xiii, uso de cromatografia de afinidade com ìon de metal imobilizado, fibrinogênio, kit farmacêutico, e, formulações farmacêutica e de fibrinogênio liofilizado
ATE211391T1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
ATE364079T1 (de) Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
SE9503679D0 (sv) Antioxidants
ATE394482T1 (de) Verfahren und zusammensetzungen für peptid-, protein- und peptidomimetische synthese
BR0312889A (pt) Polipeptìdeo t20 peguilado
SE9801494D0 (sv) Novel use
ATE433458T1 (de) Modulatoren von ship-1
BR9812773A (pt) "alfa-amino-epsilon-caprolactamas policìclicas e compostos relacionados"
ATE305037T1 (de) Peptide, die fähig sind die sh3-domäne des gap- proteins zu binden, ihre kodierende dns, ihre zubereitung und verwendung
SE9602822D0 (sv) New receptor
BR9711540A (pt) Inibidores de protease proteìnico estabilizados e variantes dos mesmos
DE50002164D1 (de) Peptide zur inhibierung von hpv e6-proteinen
DE69812597D1 (de) Peptide zur Inhibition von HPV E7 Proteinen
ATE550345T1 (de) Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties